This inventor holds 2 USPTO granted patents and 6 published patent applications. Top assignee: Zoll Circulation, Incorporated. Active years: 2026.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2026
Title: The Innovations of Stephen Elwood Myrick
Introduction
Stephen Elwood Myrick is an accomplished inventor based in Tustin, California. He holds a patent for a groundbreaking system and method for controlling oxygen-enrichment therapy based on microvascular resistance feedback. His innovative approach aims to enhance patient care through advanced gas-enrichment therapy.
Latest Patents
Myrick's notable patent, titled "System and method for controlling oxygen-enrichment therapy based on microvascular resistance feedback," provides a comprehensive solution for managing gas-enrichment therapy. This patent utilizes sensors and imaging systems to measure physiological parameters of patients, allowing for precise feedback on microvascular resistance. This feedback is crucial for titrating or controlling the gas-enrichment therapy effectively. He has been awarded 1 patent for this significant contribution to medical technology.
Career Highlights
Stephen Myrick is currently associated with Zoll Circulation, Incorporated, a company known for its commitment to advancing medical technologies. His work at Zoll Circulation focuses on developing innovative solutions that improve patient outcomes in critical care settings.
Collaborations
Myrick has collaborated with notable professionals in his field, including Jeffrey Lance Creech and Richard A Helkowski. These collaborations have contributed to the development of advanced medical technologies and have enhanced the impact of his work.
Conclusion
Stephen Elwood Myrick's contributions to the field of medical technology through his innovative patent demonstrate his commitment to improving patient care. His work continues to influence the way oxygen-enrichment therapy is administered, showcasing the importance of innovation in healthcare.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile